P14-09 Oxidative bioactivation of the sodium-glucose cotransporter 2 inhibitor Dapagliflozin: identification of potential biomarkers. (1st September 2022) - Lopes, R.P.; Sidarus, M.; Veiga, L.; Silva-Nunes, J.; Antunes, A.M.M.; Gomes, M.J.S.